Targeting the vasculature of solid tumours
- 1 October 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 48 (2-3) , 277-288
- https://doi.org/10.1016/s0168-3659(97)00038-2
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesisInternational Journal of Cancer, 1994
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation moleculeClinical and Experimental Immunology, 1992
- Inhibition of Human Corneal Epithelium with Immunotoxin 454A12-rRACornea, 1992
- Penetration of Tumor Tissue by Antibodies and Other ImmunoproteinsAnnals of the New York Academy of Sciences, 1991
- Transport of fluid and macromolecules in tumorsMicrovascular Research, 1991
- Biotechnology Update: Overview of Monoclonal Antibodies in the Diagnosis and Therapy of CancerCancer Investigation, 1991